S.3237 - Accelerating the End of Breast Cancer Act of 2012
A bill to provide for the establishment of a Commission to Accelerate the End of Breast Cancer.
Loading Bill Text
Rollover any line of text to comment and/or link to it.
Mr. WHITEHOUSE (for himself, Ms. COLLINS, Mr. BROWN of Ohio, Ms. MURKOWSKI, Mrs. SHAHEEN, Mr. HELLER, Mr. WARNER, and Mr. GRASSLEY) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and PensionsCommentsClose CommentsPermalink
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
SEC. 2. FINDINGS.
(2) Worldwide, breast cancer is the most frequently diagnosed cancer in women with 1,300,000 cases each year. Breast cancer is also the leading cause of cancer death in women, with more than 500,000 women dying from the disease worldwide in 2010.CommentsClose CommentsPermalink
(4) The National Cancer Institute estimated that breast cancer care in the United States cost $16,500,000,000 in 2009, and cost the nation $12,100,000,000 in lost productivity.CommentsClose CommentsPermalink
SEC. 3. ESTABLISHMENT.
SEC. 4. MISSION; DUTIES.
(1) identify opportunities and ideas within the public and private sectors, basic and applied sciences, and epidemiology that can be turned into real world strategies to prevent breast cancer and breast cancer metastasis;CommentsClose CommentsPermalink
(5) identify promising but underdeveloped areas of research that would benefit from a cluster of support from government, industry, and academia to rapidly advance knowledge into practice; andCommentsClose CommentsPermalink
(c) Strategic Vision- Not later than 6 months after the appointment of the initial members of the Commission, the Commission shall submit to the President and to the relevant authorizing and appropriations committees of Congress, a description of the Commission’s strategic vision for its role in achieving the mission described in subsection (a) by January 1, 2020.CommentsClose CommentsPermalink
(d) Annual Report- Not later than January 15, 2013, and annually thereafter, the Commission shall submit an annual report to the President, Congress, and the public describing--CommentsClose CommentsPermalink
SEC. 5. MEMBERSHIP.
(a) Number; Appointment- The Commission shall be composed of not more than 10 members who shall be appointed by the President, by and with the advice and consent of the Senate.CommentsClose CommentsPermalink
(2) VACANCIES- Any member of the Commission appointed to fill a vacancy occurring before the expiration of the term for which the member’s predecessor was appointed shall be appointed only for the remainder of that term. A member may serve after the expiration of that member’s term until a successor has taken office. A vacancy in the Commission shall be filled in the manner in which the original appointment was made.CommentsClose CommentsPermalink
SEC. 6. CHAIRPERSON; PROGRAM MANAGERS.
(1) DESIGNATION- Of the members of the Commission appointed under section 5(a), the President shall at the time of the appointment, designate one such member who meets the qualification requirement of paragraph (2) to serve as the Chairperson of the Commission.CommentsClose CommentsPermalink
(2) QUALIFICATIONS- To be selected as Chairperson under paragraph (1), a member shall be an individual who, by reason of professional background and experience, is especially qualified to manage areas of study pertaining to ending breast cancer by January 1, 2020.CommentsClose CommentsPermalink
(1) IN GENERAL- The Chairperson of the Commission may designate members of the Commission who may act as program managers to oversee one or more areas of study of the Commission.CommentsClose CommentsPermalink
(A) recommending novel proposals, projects, and collaborations based on scientific and technical merit to achieve the mission described in section 4(a) with a focus on strategies for the primary prevention of breast cancer, and methods to prevent breast cancer metastasis;CommentsClose CommentsPermalink
(B) identifying innovative ideas and opportunities to achieve the mission described in section 4(a), including such ideas and opportunities not being prioritized for breast cancer relevance within Federal agencies or programs or the private sector;CommentsClose CommentsPermalink
SEC. 7. COORDINATION AND NONDUPLICATION.
To the maximum extent practicable, the Commission shall ensure that the activities of the Commission are coordinated with, and do not duplicate the efforts of, programs and laboratories of other government agencies.CommentsClose CommentsPermalink
SEC. 8. EVALUATION OF THE COMMISSION.
(a) In General- The President shall enter into an agreement with the Institute of Medicine of the National Academy of Sciences under which the Institute, after the Commission has been in operation for 3 years, shall complete an evaluation of how well the Commission is making progress towards achieving the mission described in section 4(a).CommentsClose CommentsPermalink
SEC. 9. AUTHORIZATION OF FUNDING.
(a) Fund- There is established in the Treasury of the United States a fund, to be known as the ‘Accelerating the End of Breast Cancer Fund’, which shall be administered by the Chairperson, as defined in section 6(a), for the purpose of carrying out this section.CommentsClose CommentsPermalink
(c) Limitation- None of the amounts appropriated for a fiscal year under subsection (b) shall be used for the operation or construction of any laboratories or pilot plants.CommentsClose CommentsPermalink